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Abstract
The adipocyte-derived hormone leptin acts in the brain to reduce body weight and fat mass. Recent studies suggest that
parvocellular oxytocin (OXT) neurons of the hypothalamic paraventricular nucleus (PVN) can mediate body weight
reduction through inhibition of food intake and increased energy expenditure. However, the role of OXT neurons of the PVN
as a primary target of leptin has not been investigated. Here, we studied the potential role of OXT neurons of the PVN in
leptin-mediated effects on body weight regulation in fasted rats. We demonstrated that intracerebroventricular (ICV) leptin
activates STAT3 phosphorylation in OXT neurons of the PVN, showed that this occurs in a subpopulation of OXT neurons
that innervate the nucleus of the solitary tract (NTS), and provided further evidence suggesting a role of OXT to mediate
leptin’s actions on body weight. In addition, our results indicated that OXT neurons are responsive to ICV leptin and mediate
leptin effects on body weight in diet induced obese (DIO) rats, which are resistant to the anorectic effects of the hormone.
Thus, we conclude that leptin targets a specific subpopulation of parvocellular OXT neurons of the PVN, and that this action
may be important for leptin’s ability to reduce body weight in both control and obese rats.
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Introduction
The adipocyte-derived hormone leptin regulates key behavioral,
autonomic and neuroendocrine responses necessary to maintain
body energy balance [1]. Leptin acts in the brain to reduce body
weight and fat mass through inhibition of food intake and
increased energy expenditure [1]. Leptin actions are mediated by
the leptin receptor (LepR), which is expressed in several brain
regions [2,3]. Among them, the hypothalamic arcuate nucleus
(ARC) has become major focus in the leptin-mediated regulation
of energy balance field [4]. In contrast, leptin action on other
hypothalamic regions has received less attention. The PVN is
another key site for maintaining energy balance [5]. We, and
others, have contributed to show that leptin can directly activate
some PVN neurons, such the hypophysiotropic thyrotropin
releasing hormone (TRH) neurons that regulate the hypothalam-
ic-pituitary-thyroid axis [6–9]. However, other leptin targets
within the PVN are not well established. Recent studies suggest
that parvocellular OXT neurons of the PVN are able to inhibit
food intake and increase energy expenditure [10–16]. Despite that
OXT neurons express LepR [17], the potential role of these
neurons as a primary target of leptin has not been investigated.
Thus, an aim of this study was to test the hypothesis that leptin
activates OXT neurons of the PVN and that this action affects
body weight.
A better understanding of the neural circuits by which leptin
regulate body weight is essential to develop new strategies for the
treatment of obesity. Most obese people exhibit elevated circulat-
ing leptin levels that fail to suppress feeding or prevent body
weight gain [1]. Although a number of mechanisms have been
proposed to explain this leptin resistance, the molecular reasons
that cause this state are still under debate [18]. A classical animal
model of obesity is DIO rodents, which are unresponsive to the
anorectic effect of leptin [19,20]. Interestingly, the decrease in
leptin signaling observed in DIO models specifically occurs in the
ARC but not in other leptin-responsive sites of the hypothalamus
[21–23]. For instance, we have shown that TRH neurons of the
PVN in DIO animals remain sensitive to the direct action of leptin
and that the hyperleptinemic state of obese animals affects the set
point of the hypothalamic-pituitary-thyroid axis [23]. In addition,
a recent study by Enriori et al. showed that leptin activates
hypothalamic dorsomedial nucleus in DIO rodents causing
sympathetic activation and increase of brown adipose tissue
(BAT) temperature [24]. Whether additional hypothalamic
neuronal populations remain sensitive to leptin in DIO animals
is currently unknown. Thus, we also tested the hypothesis that
OXT neurons of the PVN remain sensitive to leptin in DIO
animals.
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Materials and Methods
Animals and Stereotaxic Surgeries
Male Sprague-Dawley rats were generated in the animal facility
of the IMBICE. At 22 days of age, rats were fed a regular
(3.3 kcal/g of energy, 12.1% fat) or high fat rodent (5.24 kcal/g of
energy, 60.0% fat) diets, as done in the past [23]. Food and water
were available ad libitum unless otherwise indicated. For the studies,
rats fed on regular or high fat diet for 12 weeks were stereotaxically
implanted with an ICV 21-gauge guide cannula (Plastic One), as
previously detailed [23]. The placement coordinates for the lateral
ventricle were: AP 20.8 mm to bregma, L 2.2 mm and V
23.6 mm. After surgery, ICV-cannulated rats were caged
individually and allowed to recover for 6–7 days. Correct
placement of the cannulas was verified by measurement of water
intake in response to ICV Angiotensin II [23]. This study was
carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health, and all efforts were made to minimize
suffering. The protocol was approved by the Institutional Animal
Care and Use Committee of the Multidisciplinary Institute of Cell
Biology (approval ID 10-0113).
Tracing Studies
The retrograde tracer fluoro-gold (FG, Molecular Probes) was
used to trace PVN projections. To label PVN neurons sending
terminals to the posterior pituitary gland, ICV-cannulated rats
were injected intraperitoneally with FG (15 mg/kg body weight of
2.5% solution in saline) 48 h before perfusion [23]. To label
neurons sending terminals to the NTS, FG was stereotaxically
microinjected bilaterally into this nucleus. The placement coordi-
nates were: AP 24.3 mm to interaural line, L 0.9 mm and V
27.1 mm. Our goal was to hit mainly the medial and gelatinosus
subdivisions of the NTS, which received the densest OXT axon
Figure 1. ICV leptin increased pSTAT3 in OXT neurons of the PVN in fasted control rats. Left and right upper sets of panels depict low
magnification photomicrographs of the anterior, medial and posterior parts of the PVN in fasted control rats treated with vehicle or leptin,
respectively. Red fluorescent and brown signals label NPI-IR and pSTAT3-IR cells, respectively. Double pSTAT3/NPI-IR cells are shown in the merge
panels. Bottom set of panels show high magnification photomicrographs of area marked in low magnification images; arrows point to dual-labeled
cells. Scale bars: 50 mm (Upper panels), 20 mm (Bottom panels).
doi:10.1371/journal.pone.0059625.g001
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innervations [25]. These coordinates were initially obtained from
the Paxinos and Watson atlas [26] and then modified based on
analysis of the injection sites in pilot studies. A 0.4 mL volume of
0.2% FG in saline was injected via a 33-gauge injector. Same day,
rats were implanted with an ICV cannula. We then waited 6 days
for retrograde transport of the FG before starting the experiment.
Experimental Designs
1- ICV leptin treatment in fasted rats and
neuroanatomical studies. ICV-cannulated rats were fasted
for 48 h, beginning at 12:00 p.m. Between 12:00 and 1:00 p.m. on
the third day, fasted rats ICV injected given with vehicle (artificial
cerebrospinal fluid [23]) alone or containing recombinant murine
leptin (3.5 mg/rat, obtained from Dr. E. Parlow of The National
Hormone and Pituitary Program). All ICV injections were made
in freely moving rats through a 30 gauge needle that extends
0.5 mm below the guide cannula. After 30 min, rats were
anesthetized and systemically perfused with 4% paraformalde-
hyde. Blood samples were taken to measure plasma leptin levels
using commercial RIA kits (Linco Research). Brains were then
removed, post-fixed and cryoprotected in 20% sucrose solution.
Brains were frozen, cut in 3 series of 25-mm-thick coronal sections,
which were used for immunohistochemistry. Neuroanatomical
studies were performed in vehicle- and leptin-treated control (n = 3
and 5, respectively) and DIO (n= 3 and 5, respectively) rats. Also,
we used ICV leptin injections in control rats that had FG
injections performed either systemically (n = 5) or in the NTS
(n= 7). Of note, stereotaxic microinjections of FG in the NTS
resulted in 3 missed injections centered outside of either the medial
or gelatinosus subdivisions; these rats were excluded of the
analysis.
2- ICV leptin treatment in fasted rats and gene expression
analysis. ICV-cannulated control and DIO rats were divided
into three groups fed, fasted and fasted plus leptin. The fed group
was allowed free access to food and ICV-injected with vehicle
(n = 5 and 6 for control and DIO group, respectively). The second
group was fasted for 48 h, beginning at 12:00 p.m. and ending
between 12:00 and 1:00 p.m. on the third day, and ICV-injected
Figure 2. ICV leptin failed to increase pSTAT3 in OXT neurons of the PVN belonging to the hypophyseal system. Upper sets of panels
depict low magnification photomicrographs of the anterior, medial and posterior parts of the PVN of fasted rats subjected to intraperitoneal FG
injection, ICV leptin treatment and further triple NPI, FG and pSTAT3 staining. Right column of images shows merge of NPI (red fluorescent staining),
FG (green fluorescent staining) and pSTAT3 (brown staining) signals. Bottom set of panels show high magnification photomicrographs of area
marked in low magnification images. Numbered arrows point to dual-labeled cells as follows: 1-double pSTAT3/FG-IR cell, negative for NPI; 2-double
pSTAT3/NPI-IR cell, negative for FG; 3-double FG/NPI-IR cell, negative for pSTAT3. Scale bars: 50 mm (Upper panels), 20 mm (Bottom panels).
doi:10.1371/journal.pone.0059625.g002
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with vehicle, as described below (n= 13 and 7 for control and DIO
groups, respectively). Fasted plus leptin group was performed using
two different protocols. In one set of fasted rats, leptin (3.5 mg/rat)
was administered ICV once between 12:00 and 12:30 p.m. on the
third day of fasting, and rats were sacrificed 2 h later (n = 5). In
other set of fasted rats, leptin (3.5 mg/rat) was ICV administered
every 6 h, beginning 6 h after the removal of food and ending 6 h
after completion of 48 h of fasting (n = 7 and 6 for control and
DIO groups, respectively). Rats were weighed and sacrificed by
decapitation around 12:00 p.m. on the third day of fasting. The
PVN-enriched sections (hereafter referred to as PVN) were
dissected out for mRNA quantifications. Brains were dissected
and sectioned into 1 mm coronal slices as described in the past
[27,28]. Micro-dissections of tissue corresponding to the location
of the PVN, identified by comparing the coronal slices to a rat
brain atlas of Paxinos and Watson [26], were excised using a 15 g
needle. The PVN punches sections were collected in TRIzol
Reagent (Invitrogen) for RNA isolation.
3- OXT blockage in ICV vehicle- and leptin-treated fasted
rats. ICV-cannulated control and DIO rats were fasted for
48 h, beginning at 12:00 p.m and ending at 12:00 p.m on the
third day, and ICV-injected with vehicle containing an OXT
receptor antagonist [25 ng/rat (b-mercapto-b,b cyclopentamethy-
lenepropionyl1, O-Me-Tyr2, Orn8)-OXT; Sigma Aldrich] alone or
plus leptin (3.5 mg/rat). ICV administrations were performed
every 6 h, beginning 6 h after the removal of food and ending 6 h
after completion of 48 h of fasting, when body weight of rats was
determined. All experimental groups had 6 rats.
Immunohistochemistry (IHC)
Immunostaining was performed as described before [7]. Briefly,
coronal section were sequentially treated with 1% H2O2, 0.03%
SDS and 4% normal donkey serum and then incubated with
rabbit anti-phosphorylated signal transducer and activator of
transcription 3 (pSTAT3) antibody [1:1500, Cell Signaling, cat.
#9145] overnight at 4uC. Next day, sections were incubated with
biotinylated donkey anti-rabbit antibody (1:1,000), followed by
avidin-biotin complex solution and brown precipitate development
by diaminobenzidine solution. Then, brain slices were incubated
overnight at 4uC with goat anti-Neurophysin I (NPI) antibody
Figure 3. ICV leptin increased pSTAT3 in OXT neurons of the PVN projecting to the NTS. Upper sets of panels depict low magnification
photomicrographs of the anterior, medial and posterior parts of the PVN of rats with stereotaxic injections of FG in the NTS and ICV treated with
leptin. Right column of images shows merge of NPI (red fluorescent staining), FG (green fluorescent staining) and pSTAT3 (brown staining) signals.
Bottom set of panels show high magnification photomicrographs of area marked in low magnification images, with arrow pointing to a triple-labeled
cell. Scale bars: 50 mm (Upper panels), 20 mm (Bottom panels).
doi:10.1371/journal.pone.0059625.g003
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(1:5,000, Santa Cruz, cat sc-7810). NPI is a protein synthesized
from the same OXT precursor extensively validated and used to
identify OXT-producing neurons [29]. Next day, sections were
incubated with red fluorescent donkey anti-goat Alexa 594
antibody (Molecular Probes), mounted and cover slipped in a
fluorescence mounting solution. In tracing studies, triple
pSTAT3/NPI/FG immunostaining was performed in order to
increase the FG fluorescent signal. FG staining was performed by
overnight incubation with guinea pig anti-FG antibody (1:3,000,
Protos Biotech) at 4uC, and then visualization was done with
donkey anti-guinea pig Alexa 488 antibody (Molecular Probes).
Results were visualized using either fluorescence (NPI and FG) or
bright-field light (pSTAT3) sources. Images were acquired with a
Nikon E800 microscope and a Spot II digital camera (Diagnostic
Instruments). Adobe Photoshop CS2 software was used to adjust
levels, contrast and brightness and to combine fluorescence and
bright-field images.
Quantitative Neuroanatomical Analysis
Double-labeled and triple-labeled sections were used for
quantitative analysis. Total NPI-immunoreactive (IR) neurons
and NPI-IR neurons with nuclei positive for pSTAT3 were
counted on each side of the third ventricle. The relationship was
expressed as a percentage, which represents NPI-IR cells positive
for pSTAT3 compared to the total number of NPI-IR cells
observed [8]. Quantifications were performed in complete series of
coronal sections and then numbers were multiply by three. Data
were corrected for double counting, according to the method of
Abercrombie [30], where the ratio of the actual number of
neurons to the observed number is represented by T/(T+h) where
T= section thickness, and h= the mean diameter of the neuron.
For this, average NPI-IR cell diameter, in at least 40 cells per
PVN, was quantified using NIH image software Image J in each
experimental group. In the case of triple staining, we quantified all
double labeled FG/NPI-IR, single labeled FG-IR (which were
negative for NPI) and single labeled NPI-IR (which were negative
for FG) neurons of the PVN and then calculate the percentage of
them that were positive for pSTAT3.
Gene Expression Analysis
Total RNA was isolated using TRIzol Reagent and quantified
by absorbance at 260 nm. Total RNA was treated with DNase I
(Roche). cDNA synthesis was generated using random hexamer
primers and SuperScript III reverse transcriptase (Invitrogen).
Quantitative real-time PCRs were done using the SYBR GreenH
PCR Core Reagents and the ABI 7500 Fast-Real time PCR
system (Applied Biosystems). Averaged mRNA levels of OXT were
normalized to the housekeeping gene hypoxanthine phosphor-
ibosyl transferase (hprt1), calculated by the comparative threshold
cycle (Ct) method [31], and presented as relative of levels observed
in PVN of control fed rats. Primers sequences were: upstream
OXT, 59-TGCCCCAGTCTCGCTTGCT-39; downstream OXT,
59-TCCAGGTCTAGCGCAGCCC-39; upstream hprt1, 59-GCA-
GACTTTGCTTTCCTTGG-39; downstream hprt1, 59-
GTCTGGCCTGTATCCAACACT-39. All reactions were per-
formed per triplicate. Standard curves for OXT and hprt 1
transcript levels were generated using hypothalamic cDNA of
control fed rat.
Statistical Analyses
Data is expressed as the mean6SEM. The t-test was used to
compare percentage NPI-IR neurons positive for pSTAT3 of the
PVN in vehicle- vs. leptin-treated groups. Also, t-test was
performed when comparing data of control vs. DIO groups or
vehicle vs. leptin effects on the different experimental paradigms.
One-way ANOVA was performed when comparing OXT mRNA
levels. Two-way ANOVA, with leptin and OXT receptor
antagonist as factors, was performed when comparing body
weight data. Significant differences were considered when p,0.05.
Results
Leptin Activates OXT Neurons of the PVN
To test if OXT neurons respond to leptin, we performed double
IHC for pSTAT3 and NPI, as a marker of OXT producing
neurons, in leptin- and vehicle-treated fasted rats. Red NPI signal
was confined to the perikarya and dendrites. FG signal was seen as
cytoplasmic granular green staining. PSTAT3 signal was seen as
nuclear brown labeling. Figure 1 depicts a set of representative
images of three levels of the PVN of rats subjected to vehicle or
leptin treatments. NPI-IR cells were concentrated in the magno-
cellular division of the PVN but also scattered found within all five
Figure 4. ICV leptin affected OXT gene expression in the PVN
(A) and required OXT signaling to regulate body weight in
fasted control rats (B). A. OXT mRNA levels of ad libitum fed, fasted
and leptin-treated fasted rats are presented as relative of levels
observed in PVN of control fed rats. B. Body weight was determined
after completion of 48 h fasting and simultaneous ICV administrations,
every 6 h, of either vehicle or leptin in presence or absence of the OXT
receptor antagonist. *, p,0.05. **, p,0.01. n.s., not significant.
doi:10.1371/journal.pone.0059625.g004
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parts of the parvocellular division of the PVN, as previously
described [32]. Total number of NPI-IR cells of the PVN was not
significantly affected by leptin (13816203 and 14676219 cells in
vehicle- and leptin-groups, respectively). We found no NPI-IR
neurons positive for pSTAT3 in vehicle-treated rats, while
6.262.1% of NPI-IR neurons of the PVN were positive for
pSTAT3 in leptin-treated rats (p,0.01 vs. vehicle-treated rats).
Thus, leptin is able to act on some OXT neurons of the PVN.
OXT Neurons Responsive to Leptin Innervate the NTS
Initially, we tested if leptin-responsive OXT neurons send their
axons terminals outside of the blood-brain barrier [33]. Figure 2
depicts a set of representative images of the PVN of fasted rats
subjected to intraperitoneal FG injection, ICV leptin treatment
and further triple NPI, FG and pSTAT3 staining. Double FG/
NPI-IR cells were located in the anterior, medial and posterior
parts of the magnocellular division of the PVN and estimated in
9686163 cells. All double FG/NPI-IR neurons of the PVN were
negative for pSTAT3. Single NPI-IR cells were found scattered
within all parts of the parvocellular division of the PVN and
estimated in 419676 cells. Quantitative analysis indicated that
1865% of these single NPI-IR cells were positive for pSTAT3. Of
note, a fraction (,21%) of single FG-IR neurons of the PVN was
positive for pSTAT3. Thus, leptin-responsive OXT neurons do
not belong to the hypophyseal system, and a fraction of the leptin-
responsive non-OXT neurons does project to the pituitary gland.
OXT parvocellular neurons of the PVN project to specific
autonomic preganglionic neurons located in the intermedio-lateral
cell column of the spinal cord and in the NTS [32]. However,
leptin-activated neurons of the PVN do not innervate pre-
ganglionic neurons in the spinal cord [34]. Thus, we tested if
leptin-responsive OXT neurons send their projections to the NTS.
Figure 3 depicts a set of representative images of the PVN of fasted
rats subjected to FG injection in the NTS, ICV leptin treatment
and further triple NPI, FG and pSTAT3 staining. As previously
reported, FG-IR cells were scattered mostly within the dorsal,
Figure 5. ICV leptin increased pSTAT3 in OXT neurons of the PVN in DIO rats. Left and right upper sets of panels depict low magnification
photomicrographs of the anterior, medial and posterior parts of the PVN in DIO rats treated with vehicle or leptin, respectively. Red fluorescent and
brown signals represent NPI-IR and pSTAT3-IR, respectively. Cells with co-localization of NPI-IR with pSTAT3-IR are seen in the merge panels. Bottom
set of panels show high magnification photomicrographs of area marked in low magnification images, with arrows pointing to dual-labeled cells.
Scale bars: 50 mm (Upper panels), 20 mm (Bottom panels).
doi:10.1371/journal.pone.0059625.g005
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lateral and medial parvocellular regions of the PVN [32]. No
double FG/NPI-IR cells were observed outside the PVN. Double
FG/NPI-IR cells were concentrated in the caudal part of the
parvocellular division of the PVN and estimated in 108616 cells.
Quantitative analysis indicated that 65.768.9% of double FG/
NPI-IR neurons of the PVN were positive for pSTAT3.
Interestingly, a fraction (,19%) of single FG-IR neurons of the
PVN was positive for pSTAT3. Of note, all single NPI-IR neurons
were negative for pSTAT3. Thus, our data suggest that leptin
exclusively activates OXT neurons of the parvocellular PVN that
innervate the NTS.
Leptin Affects OXT Gene Expression in the PVN
We next determined if leptin action on OXT neurons affects the
neuropeptide gene expression. Plasma leptin levels were signifi-
cantly decreased in control fasted rats (2.160.5 vs. 6.261.3 ng/
mL in fed condition). As shown in Figure 4A, OXT mRNA levels
in the PVN significantly decreased in fasted rats as compared to
fed group (0.5560.06 vs. 1.0060.06 relative levels, p,0.01). Two
hour after ICV leptin treatment, OXT mRNA levels in the PVN
were unchanged (0.5960.05 relative levels). Thus, we used a
different protocol in which rats were ICV treated with leptin every
6 h during the fasting period. Using this protocol, we found that
leptin significantly increased OXT mRNA levels in the PVN
(0.7660.07 relative levels, p,0.01 as compared to fasted rats
treated with vehicle). As shown in Figure 4B, fasted rats receiving
ICV leptin showed a further reduction of body weight, as
compared to fasted rats treated with vehicle (264610 vs.
325615 g, respectively, p,0.01). Thus, our findings suggest that
ICV leptin increases OXT mRNA levels in the PVN of fasted rats.
Leptin Requires OXT Signaling to Regulate Body Weight
in Fasted Rats
Then, we tested the effect of an OXT receptor antagonist on
leptin-induced reduction of body weight. ICV treatment of fasted
rats with the OXT receptor antagonist alone did not affect body
weight (319618 g), as compared to fasted rats treated with vehicle.
Fasted rats receiving leptin and OXT receptor antagonist had a
body weight of 293612 g, which was not significantly different of
the body weight of fasted rats receiving an OXT receptor
antagonist alone (Figure 4B). Thus, OXT signaling blockage
attenuates the leptin-induced reduction of body weight in fasted
rats.
Leptin Activates OXT Neurons of the PVN in DIO Rats
We recently reported that DIO rats fed on high fat diet for 12
weeks are leptin resistant [23]: i-DIO rats are heavier and have
higher plasma leptin concentrations than rats fed on regular chow;
ii-ICV leptin fails to affect food intake of DIO rats; and iii-ICV
leptin-induced increase of pSTAT3-IR cells in the ARC of fasted
DIO rats is reduced by ,50% as compared to control rats. In
order to test if leptin activates OXT neurons in DIO rats, we
performed double IHC for pSTAT3 and NPI in ICV leptin- and
vehicle-treated fasted DIO animals. Total NPI-IR cells of the PVN
in DIO rats were estimated in 13716152 cells. Figure 5 depicts a
set of representative images of three levels of the PVN of DIO rats
subjected to vehicle or leptin treatments. We found no NPI-IR
neurons positive for pSTAT3 in vehicle-treated DIO rats, while
7.161.8% of NPI-IR neurons of the PVN were positive for
pSTAT3 in leptin-treated DIO rats (p,0.01). Of note, all NPI-IR
cells positive for pSTAT3 were located in the parvocellular part of
the PVN. Thus, ICV leptin is able to act on some OXT neurons of
the PVN in fasted DIO rats.
We next tested if leptin affects OXT gene expression in the
PVN of DIO rats. Ad libitum fed DIO rats had OXT mRNA levels
in the PVN similar to fed control rats (1.0360.07 vs. 1.0060.06
relative levels, respectively). As shown in Figure 6A, OXT mRNA
levels in the PVN of DIO rats were down regulated by fasting
(0.5960.05 relative levels, p,0.01 vs. fed condition) and reversed
by leptin treatment (0.8360.06 relative levels, p,0.01 vs. vehicle-
treated fasted DIO rats), in a similar fashion as observed in control
rats. As shown in Figure 6B, fasted DIO rats receiving leptin had a
significant reduction in body weight as compared to fasted DIO
rats treated with vehicle (414612 vs. 493612 g, respectively,
p,0.01). In contrast, fasted DIO rats receiving leptin and the
OXT receptor antagonist failed to show any significant reduction
in body weight as compared to fasted rats treated with the OXT
receptor antagonist alone (454618 vs. 497619 g, respectively).
Thus, ICV leptin regulates OXT mRNA levels in the PVN, and
OXT signaling contributes to leptin-induced decrease of body
weight in fasted DIO rats.
Figure 6. ICV leptin affected OXT gene expression in the PVN
(A) and required OXT signaling to regulate body weight (B) in
fasted DIO rats. A. OXT mRNA levels are presented as relative to
levels observed in PVN of control fed rats. B. Body weight was
determined after completion of 48 h fasting and simultaneous ICV
administrations, every 6 h, of either vehicle or leptin in presence or
absence of the OXT receptor antagonist. *, p,0.05. **, p,0.01. n.s., not
significant.
doi:10.1371/journal.pone.0059625.g006
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Discussion
Here, we show that ICV leptin increases pSTAT3 in the OXT
neurons of the PVN that innervate the NTS. In addition, we show
that ICV leptin is able to regulate OXT mRNA levels in the PVN,
and that OXT signaling may be involved in leptin-mediated
regulation of body weight. This finding supports previous studies
showing that OXT neurons of the PVN link the hypothalamic
action of leptin to the NTS to control body weight [14], and
provide further evidence suggesting that these neurons may be a
direct target of leptin. We also show that ICV leptin activates
OXT neurons of the PVN in obese rats, and that this action affects
body weight of DIO rats in our experimental conditions.
Recent evidence has highlighted the role of OXT in the central
regulation of body weight [35]. Similarly to leptin, OXT reduces
body weight and fat mass through inhibition of food intake and
increased energy expenditure. OXT or OXT antagonist admin-
istration reduces or increases food intake, respectively [36–40].
Also, OXT mRNA levels in the PVN are decreased and increased
by fasting and re-feeding, respectively [10,11]. Interestingly, OXT
deficiency in the PVN mediates hyperphagia and obesity in mice
with heterozygous inactivation of the transcription factor single-
minded 1 [11]. Of note, OXT also increases energy expenditure
since OXT or OXT receptor-deficient mice display low sympa-
thetic tone and increased body weight and fat mass without
hyperphagia [12,13]. In addition, mice with genetic ablation of the
OXT neurons are more sensitive to DIO specifically due to a
energy expenditure reduction [15]. It had been previously shown
that leptin inhibition of food intake is partially mediated by OXT
neurons of the PVN [14]. Our current findings provide the first
evidence of a link between OXT and leptin-induced increase of
energy expenditure. In order to make apparent the leptin effect on
energy expenditure, we ICV administrated leptin to fasted rats, in
which the anorexic effect of the hormone is removed by
eliminating food intake. The leptin-induced reduction in body
weight observed in fasted animals occurs because leptin admin-
istration partially prevents the reduction of energy expenditure
normally associated to fasting [41]. Here, we show that the further
reduction in body weight observed in fasted animals ICV treated
with leptin is attenuated by an OXT receptor antagonist, at a dose
that had no independent effects on body weight. Thus, ICV leptin
can elicit body weight changes through OXT signaling in fasted
rats. However, these results should not be generalized to
physiological effects of leptin on body weight regulation since
they were obtained under some specific experimental conditions.
Since OXT neurons of the PVN provide the largest contribution
that control BAT functions [32,42], it could be hypothesized that
these neurons mediate leptin regulation of thermogenesis in BAT.
OXT blockade may also cause a reduction of leptin-induced
increase of other sympathetic functions and/or locomotor activity
[43,44]. Future studies will be required to test these possibilities.
Here, we show that leptin increases pSTAT3 exclusively in
OXT neurons of the parvocellular PVN that innervate the NTS.
The parvocellular OXT neurons give rise to the greater number of
projections from the PVN to the brainstem, where they innervate
several nuclei including the NTS [32], and these projections are
essential for body weight regulation [45]. The NTS, which
expresses high levels of OXT receptors [46,47] and receives dense
OXT innervations solely from parvocellular PVN neurons
[25,48], is known to mediate some actions of leptin on energy
balance [10]. In addition, viral retrograde transynaptic studies
found that the NTS participates of the neuronal circuitry
regulating sympathetic outflow to BAT [49]. Thus, previous
neuroanatomical studies support the possibility that innervations
of OXT neurons of the PVN to NTS neurons could contribute to
mediate effects on energy expenditure.
Direct leptin targets include mainly the ARC, where circulating
factors has preferential access; however, leptin can also impact on
other hypothalamic nuclei such as the PVN [2–4,17,50]. There is
compelling evidence supporting the direct action of leptin on the
rat PVN, where: i-LepR mRNA and protein are present [3,17]; ii-
peripheral and central leptin administration induces pSTAT3
[7,8,23,51]; iii-leptin administration activates gene expression of
suppressor-of-cytokine-signaling 3, another marker of direct leptin
action [9]; iv-leptin depolarizes neurons [52]; and v-micro-
injection of leptin affects some gastrointestinal functions [53].
The STAT3 phosphorylation has been extensively used as a direct
measure of LepR activation since it is activated at areas that
overlap well with LepR mRNA expression [3,54,55]. In addition,
neuronal deletion of STAT3 protein or STAT3 binding site on
LepR in mice reproduces the metabolic phenotype of the LepR
null animal [56,57]. Thus, our data can be interpreted as leptin
directly regulates a subpopulation of OXT neurons of the PVN. In
the current study, leptin was ICV-administrated in order to rule
out any potential contribution of peripheral actions of the
hormone. Under physiological conditions, however, the action of
circulating leptin on the PVN depends also on the blood–brain
barrier transport regulation and on ARC-dependent pathways,
which are particularly sensitive to plasma factors. Thus, the
relevance of direct leptin signaling on OXT neurons of the PVN
under physiological conditions requires further studies.
Our current neuroanatomical findings raise additional and
interesting considerations. When neurons belonging to the
hypophyseal system were labeled (Figure 2), we observed single
FG-IR cells positive of pSTAT3. These neurons, which are
presumably a direct target of leptin, include likely TRH neurons
since we have shown that leptin activates hypophysiotropic TRH
neurons [23]. When neurons innervating the NTS were labeled
(Figure 3), we found that all OXT neurons of the PVN negative
for FG also lacked pSTAT3 labeling. Therefore, no other
subpopulation of OXT neurons of the PVN seems to be affected
by leptin. In this tracing study, we also observed single FG-IR cells
positive for pSTAT3 that were negative for NPI. Thus, the PVN
may contain non-OXT neurons that innervate the NTS and
increase pSTAT3 in response to leptin. Interestingly, Elias et al.
have shown that very few leptin-activated neurons of the PVN
innervate sympathetic pre-ganglionic neurons in the thoracic
spinal cord [34]. Thus, the NTS may be one of the main targets of
the leptin-responsive neurons of the PVN. Of note, it is also
plausible that leptin regulates additional OXT neurons of the
PVN in a pSTAT3-independent fashion, for instance via the
melanocortin system [58].
Leptin resistance is a common feature seen in obese patients
that has limited the use of leptin for the treatment of obesity [1].
Studies in DIO rodents, which are widely used as a model of
human obesity, have shown that the ARC is a major site of leptin
resistance while some other sites within the brain remain leptin
sensitive [21,22]. These leptin-responsive brain areas in DIO
rodents seem to be physiologically relevant as these animals
become much less obese than ob/ob mice, which completely lack
leptin signaling [22]. Over the past years, some of the specific
neuronal populations that remain leptin sensitive in DIO models
started to be identified. We have shown that hypophysiotropic
TRH neurons of the PVN remain sensitive to leptin in DIO
animals [23]. Additionally, neurons of the hypothalamic dorso-
medial nucleus have been shown to remain sensitive to the direct
action of leptin in DIO rodents [24]. Here we propose that
parvocellular OXT neurons of the PVN could be included as
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another set of leptin sensitive neurons in DIO animals. According
to this possibility, Wu et al. have shown an obligate role of OXT
neurons in diet-induced energy expenditure in mice [15].
Interestingly, recent evidences indicate that OXT treatment
reduces obesity, food intake and fat mass in DIO animals
[59,60]. Thus, pharmacological manipulations of OXT system
may be a potential target for treating body weight-related
disorders.
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